Author

N. Iwayama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:metagenomics· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

K. A. Guerriero· 2 shared S. Wangari· 2 shared A. Khandhar· 1 shared A. T. Gustin· 1 shared B. Brown· 1 shared C. A. Broedlow· 1 shared C. Ahrens· 1 shared C. Y. Ahrens· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

K. A. Guerriero

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

High-risk microbial signatures are associated with severe parasitemia in controlled Plasmodium infections of both humans and rhesus macaques

A. T. Gustin, C. A. Broedlow, K. Hager, E. Coronado, S. Wangari, N. Iwayama, C. Y. Ahrens, W. D. Garrison, K. A. Guerriero, K. De Paris, M. Gale, N. R. Klatt, J. G. Kublin, J. A. Manuzak

The paper identifies a high-risk microbial signature in the gut microbiome associated with severe parasitemia in both humans and rhesus macaques during controlled Plasmodium infections.

bioRxiv · Sep 6, 2022Microbiology

A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned

M. A. O'Connor, D. W. Hawman, K. Meade-White, S. Leventhal, W. Song, S. Randall, J. Archer, T. B. Lewis, B. Brown, N. Iwayama, C. Ahrens, W. Garrison, S. Wangari, K. A. Guerriero, P. Hanley, , J. H. Erasmus

This study shows a replicon RNA vaccine provides durable protection against SARS-CoV-2 in nonhuman primates even after neutralizing antibodies decline.

bioRxiv · Aug 8, 2022 · PreprintImmunology